BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32926108)

  • 1. Clinical Experience of Implementing Oral Versus Intravenous Antibiotics (OVIVA) in a Specialist Orthopedic Hospital.
    Azamgarhi T; Shah A; Warren S
    Clin Infect Dis; 2021 Nov; 73(9):e2582-e2588. PubMed ID: 32926108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT.
    Scarborough M; Li HK; Rombach I; Zambellas R; Walker AS; McNally M; Atkins B; Kümin M; Lipsky BA; Hughes H; Bose D; Warren S; Mack D; Folb J; Moore E; Jenkins N; Hopkins S; Seaton RA; Hemsley C; Sandoe J; Aggarwal I; Ellis S; Sutherland R; Geue C; McMeekin N; Scarborough C; Paul J; Cooke G; Bostock J; Khatamzas E; Wong N; Brent A; Lomas J; Matthews P; Wangrangsimakul T; Gundle R; Rogers M; Taylor A; Thwaites GE; Bejon P
    Health Technol Assess; 2019 Aug; 23(38):1-92. PubMed ID: 31373271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral versus intravenous antibiotic treatment for bone and joint infections (OVIVA): study protocol for a randomised controlled trial.
    Li HK; Scarborough M; Zambellas R; Cooper C; Rombach I; Walker AS; Lipsky BA; Briggs A; Seaton A; Atkins B; Woodhouse A; Berendt A; Byren I; Angus B; Pandit H; Stubbs D; McNally M; Thwaites G; Bejon P
    Trials; 2015 Dec; 16():583. PubMed ID: 26690812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From 'OPAT' to 'COpAT': implications of the OVIVA study for ambulatory management of bone and joint infection.
    Seaton RA; Ritchie ND; Robb F; Stewart L; White B; Vallance C
    J Antimicrob Chemother; 2019 Aug; 74(8):2119-2121. PubMed ID: 30989175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Opportunities for Oral Antibiotic Therapy in Bone and Joint Infections.
    Bhagat H; Sikka MK; Sukerman ES; Makadia J; Lewis JS; Streifel AC
    Ann Pharmacother; 2023 Feb; 57(2):156-162. PubMed ID: 35656850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral versus Intravenous Antibiotics for Bone and Joint Infection.
    Li HK; Rombach I; Zambellas R; Walker AS; McNally MA; Atkins BL; Lipsky BA; Hughes HC; Bose D; Kümin M; Scarborough C; Matthews PC; Brent AJ; Lomas J; Gundle R; Rogers M; Taylor A; Angus B; Byren I; Berendt AR; Warren S; Fitzgerald FE; Mack DJF; Hopkins S; Folb J; Reynolds HE; Moore E; Marshall J; Jenkins N; Moran CE; Woodhouse AF; Stafford S; Seaton RA; Vallance C; Hemsley CJ; Bisnauthsing K; Sandoe JAT; Aggarwal I; Ellis SC; Bunn DJ; Sutherland RK; Barlow G; Cooper C; Geue C; McMeekin N; Briggs AH; Sendi P; Khatamzas E; Wangrangsimakul T; Wong THN; Barrett LK; Alvand A; Old CF; Bostock J; Paul J; Cooke G; Thwaites GE; Bejon P; Scarborough M;
    N Engl J Med; 2019 Jan; 380(5):425-436. PubMed ID: 30699315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Economic Impact of Implementing OVIVA Criteria on Patients With Bone and Joint Infections in Outpatient Parenteral Antimicrobial Therapy.
    Marks M; Bell LCK; Jones I; Rampling T; Kranzer K; Morris-Jones S; Logan S; Pollara G
    Clin Infect Dis; 2020 Jun; 71(1):207-210. PubMed ID: 31603189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an emergency department to outpatient parenteral antibiotic therapy program for cellulitis.
    Yadav K; Suh KN; Eagles D; Thiruganasambandamoorthy V; Wells GA; Stiell IG
    Am J Emerg Med; 2019 Nov; 37(11):2008-2014. PubMed ID: 30824277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trial.
    McMeekin N; Geue C; Briggs A; Rombach I; Li HK; Bejon P; McNally M; Atkins BL; Ferguson J; Scarborough M;
    Wellcome Open Res; 2019; 4():108. PubMed ID: 31930174
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical characteristics and outcomes of patients receiving outpatient parenteral antibiotic therapy in a Belgian setting: a single-center pilot study.
    Briquet C; Cornu O; Servais V; Blasson C; Vandeleene B; Yildiz H; Stainier A; Yombi JC
    Acta Clin Belg; 2020 Aug; 75(4):275-283. PubMed ID: 31023169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supervised self-administration of outpatient parenteral antibiotic therapy: a report from a large tertiary hospital in Australia.
    Subedi S; Looke DF; McDougall DA; Sehu MM; Playford EG
    Int J Infect Dis; 2015 Jan; 30():161-5. PubMed ID: 25603999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Program to Provide Drug Recovery Assistance and Outpatient Parenteral Antibiotic Therapy in People Who Inject Drugs.
    Gelman SS; Stenehjem E; Foster RA; Tinker N; Grisel N; Webb BJ
    Open Forum Infect Dis; 2022 Feb; 9(2):ofab629. PubMed ID: 35106314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a consensus protocol for antibiotic use for bone and joint infection to reduce unnecessary outpatient parenteral antimicrobial therapy: A quality improvement initiative.
    Suzuki H; Mosher HJ; Heintz BH; Livorsi DJ
    Antimicrob Steward Healthc Epidemiol; 2022; 2(1):e6. PubMed ID: 36310771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore.
    Chan M; Ooi CK; Wong J; Zhong L; Lye D
    BMC Infect Dis; 2017 Jul; 17(1):474. PubMed ID: 28683717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative outcomes of β-lactam antibiotics in outpatient parenteral antibiotic therapy: treatment success, readmissions and antibiotic switches.
    Lee B; Tam I; Weigel B; Breeze JL; Paulus JK; Nelson J; Allison GM
    J Antimicrob Chemother; 2015 Aug; 70(8):2389-96. PubMed ID: 26024869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service.
    Mackintosh CL; White HA; Seaton RA
    J Antimicrob Chemother; 2011 Feb; 66(2):408-15. PubMed ID: 21118914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital resource use and cost of treatment with linezolid versus teicoplanin for treatment of serious gram-positive bacterial infections among hospitalized patients from South America and Mexico: results from a multicenter trial.
    López H; Li JZ; Balan DA; Willke RJ; Rittenhouse BE; Mozaffari E; Vidal G; Zitto T; Tang T
    Clin Ther; 2003 Jun; 25(6):1846-71. PubMed ID: 12860502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential intravenous-to-oral outpatient antibiotic therapy for MRSA bacteraemia: one step closer.
    Jorgensen SCJ; Lagnf AM; Bhatia S; Shamim MD; Rybak MJ
    J Antimicrob Chemother; 2019 Feb; 74(2):489-498. PubMed ID: 30418557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effectiveness of Oral Versus Outpatient Parenteral Antibiotic Therapy for Empyema.
    Stockmann C; Ampofo K; Pavia AT; Byington CL; Sheng X; Greene TH; Korgenski EK; Hersh AL
    Hosp Pediatr; 2015 Dec; 5(12):605-12. PubMed ID: 26526596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excellent Outcomes With the Selective Use of Oral Antibiotic Therapy for Bone and Joint Infections: A Single-Center Experience.
    Halouska MA; Van Roy ZA; Lang AN; Hilbers J; Hewlett AL; Cortes-Penfield NW
    Cureus; 2022 Jul; 14(7):e26982. PubMed ID: 35989847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.